| Literature DB >> 26483290 |
Abstract
PURPOSE: The calculation of standardized mortality ratios (SMRs) is a standard tool for the estimation of health risks in occupational epidemiology. An increasing number of studies deal with the analysis of the mortality in employees suffering from an occupational disease like silicosis or coal-worker pneumoconiosis (CWP). Their focus lies not on the mortality risk due to the occupational disease itself, but on other diseases such as lung cancer or heart diseases. Using population-based reference rates in these studies can cause misleading results because mortality rates of the general population do not reflect the elevated mortality due to the occupational disease investigated. Hence, the purpose of the present paper is to develop an approach to adjust the risk estimates for other causes of death with respect to the effect of an occupational disease as a competing cause of death in occupational mortality cohort studies.Entities:
Keywords: Adjustment; Coal miners; Cohort study; Lung cancer; Pneumoconiosis; Standardized mortality ratio
Mesh:
Year: 2015 PMID: 26483290 PMCID: PMC4828478 DOI: 10.1007/s00420-015-1097-z
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Notations for statistical quantities discussed in text
| Quantity | Study cohort | Expected values* |
|---|---|---|
| Total deaths (all causes) | OBS | EXP |
| Deaths from the specific cause of interest | OBS | EXP |
| Deaths from competing cause | OBS0 | EXP0 |
| Overall standardized mortality ratio | SMR = OBS/EXP | |
| Standardized mortality ratio for cause | SMR | |
| Relative standardized mortality ratio for cause | RSMR |
* Calculated using a set of age-specific rates from the reference population
Recalculation of SMR for lung cancer in the US coal miner cohort (Attfield and Kuempel 2008)
| Subcohort | OBS | EXP | SMR | EXP* | SMR* | 95 % CI |
|---|---|---|---|---|---|---|
|
| ||||||
| CWP, Cat 0 | 294 | 260.18 | 1.13 | 246.18 | 1.19 | 1.06–1.34 |
| CWP, Cat 1 | 23 | 25.84 | 0.89 | 23.45 | 0.98 | 0.62–1.47 |
| CWP, Cat 2 | 6 | 11.32 | 0.53 | 8.01 | 0.75 | 0.27–1.63 |
| CWP, Cat 3 | 1 | 3.03 | 0.33 | 1.80 | 0.56 | 0.01–3.10 |
| PMF | 7 | 10.14 | 0.69 | 5.42 | 1.29 | 0.52–2.66 |
|
| ||||||
| Anthracite | 18 | 22.50 | 0.80 | 11.85 | 1.52 | 0.90–2.40 |
| East Appalachia | 43 | 44.79 | 0.96 | 40.46 | 1.06 | 0.77–1.43 |
| West Appalachia | 195 | 166.67 | 1.17 | 161.56 | 1.21 | 1.04–1.39 |
| Mid-west | 58 | 40.00 | 1.45 | 39.06 | 1.49 | 1.13–1.92 |
| West | 17 | 36.17 | 0.47 | 32.24 | 0.53 | 0.31–0.84 |
| Total cohort | 331 | 309.35 | 1.07 | 286.00 | 1.16 | 1.04–1.29 |
Recalculation of SMR for lung cancer in the Rhondda Fach cohort (Atuhaire et al. 1985)
| CWP category | OBS | EXP | SMR | EXP* | SMR* | 95 % CI |
|---|---|---|---|---|---|---|
| Cat 0 | 100 | 130.72 | 0.77 | 130.12 | 0.77 | 0.62–0.94 |
| Cat 1 | 22 | 35.09 | 0.63 | 34.85 | 0.63 | 0.40–0.96 |
| Cat 2 | 25 | 27.32 | 0.92 | 26.03 | 0.96 | 0.62–1.42 |
| Cat 3 | 13 | 15.15 | 0.86 | 13.83 | 0.94 | 0.50–1.61 |
| A | 12 | 17.44 | 0.69 | 14.47 | 0.83 | 0.43–1.45 |
| B and C | 19 | 20.97 | 0.91 | 10.98 | 1.73 | 1.04–2.70 |
Recalculation of SMR for lung cancer in cohorts of coal workers
| Study | Subcohort | OBS | EXP | SMR | EXP* | SMR* | 95 % CI |
|---|---|---|---|---|---|---|---|
| Meijers et al. ( | Workers with CWP | 19 | 14.50 | 1.31 | 12.63 | 1.50 | 0.91–2.35 |
| Starzynski et al. ( | Workers with CWP | 153 | 146.73 | 1.04 | 122.13 | 1.25 | 1.06–1.47 |
| Miller and MacCalman ( | 1959–1974 | 160 | 204.34 | 0.78 | 196.16 | 0.82 | 0.69–0.95 |
| Miller and MacCalman ( | 1975–1989 | 403 | 425.55 | 0.95 | 394.79 | 1.02 | 0.92–1.13 |
| Miller and MacCalman ( | 1990–2005 | 395 | 341.40 | 1.16 | 324.49 | 1.22 | 1.10–1.34 |
| Miller and MacCalman ( | 1959–2005 | 958 | 1034.56 | 0.93 | 975.29 | 0.98 | 0.92–1.05 |
| Graber et al. ( | 1969–2007 | 568 | 524.00 | 1.08 | 488.67 | 1.16 | 1.07–1.26 |
Recalculation of SMR for lung cancer among silicotic patients
| Study | Subcohort | OBS | EXP | SMR | EXP* | SMR* | 95 % CI |
|---|---|---|---|---|---|---|---|
| Starzynski et al. ( | Foundry workers | 69 | 43.39 | 1.59 | 36.13 | 1.91 | 1.49–2.42 |
| Ebihara and Kawami ( | 51 | 15.42 | 3.31 | 7.21 | 7.07 | 5.27–9.30 | |
| Carta et al. ( | 34 | 24.90 | 1.37 | 12.96 | 2.62 | 1.82–3.67 | |
| Marinaccio et al. ( | Males | 798.06 | 723.88 | 1.10 | 609.00 | 1.31 | 1.22–1.40 |
| Marinaccio et al. ( | Females | 6.06 | 6.16 | 1.07 | 5.61 | 1.18 | 0.46–2.47 |
| Scarselli et al. ( | 138.78 | 100.04 | 1.39 | 83.21 | 1.67 | 1.40–1.97 |
Recalculation of SMR for some specific causes in Rhondda Fach by category of CWP (Atuhaire et al. 1985)
| Category of CWP | 0–3 | A | B and C | |||
|---|---|---|---|---|---|---|
| Cause of death | SMR | SMR* | SMR | SMR* | SMR | SMR* |
| All cancers | 0.90 | 0.91 | 0.98 | 1.18 | 0.99 | 1.89 |
| Gastric cancer | 1.42 | 1.44 | 2.17 | 2.61 | 1.51 | 2.89 |
| Lung cancer | 0.77 | 0.78 | 0.69 | 0.83 | 0.91 | 1.73 |
| All circulatory | 1.17 | 1.19 | 0.90 | 1.08 | 0.84 | 1.60 |
| Ischemic heart disease | 1.16 | 1.18 | 0.83 | 1.01 | 0.88 | 1.68 |